Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vertex Pharmaceuticals (NQ: VRTX ) 468.71 -2.67 (-0.57%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vertex Pharmaceuticals < Previous 1 2 3 4 5 6 7 8 9 ... 48 49 Next > 2 Stocks That Could Crush the Market in 2024 February 25, 2024 These companies aren't slowing down, and their addressable markets are widening. Via The Motley Fool Three S&P 500 Giants Lead This List Of Stocks Near Buy Points February 24, 2024 Watch these five stocks, but the market is slightly extended. Via Investor's Business Daily Topics Stocks Exposures US Equities Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On. February 23, 2024 Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy. Via Investor's Business Daily The Best Stocks to Invest $5,000 in Right Now February 23, 2024 These stocks could be huge winners for long-term investors. Via The Motley Fool 3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024 February 22, 2024 With new innovation and high demand, biotech stocks could offer some of the most explosive opportunities of the year. Via InvestorPlace What Analysts Are Saying About Vertex Pharmaceuticals Stock February 20, 2024 Via Benzinga Stock-Split Watch: Is Vertex Pharmaceuticals Next? February 14, 2024 It's on track to launch more blockbuster drugs. Via The Motley Fool Could Vertex Pharmaceuticals Reach $500 in 2024? February 10, 2024 Vertex shares have several catalysts on the horizon... Via The Motley Fool 3 Secret Stocks to Double Your Money by 2028 February 22, 2024 Vertex Pharmaceuticals (VRTX), UiPath (PATH), and Science Applications International (SAIC) are 3 secret stocks to double your money by 2028. Via InvestorPlace Vertex to Participate in Upcoming Investor Conferences February 20, 2024 From Vertex Pharmaceuticals Incorporated Via Business Wire Vertex Pharmaceuticals Is About to Extend Its Leadership in This Billion-Dollar Market February 20, 2024 Vertex's main business may be heading for a new era of growth... Via The Motley Fool Cathie Wood Is Betting on This Top Technology: 2 Stocks She Just Bought February 20, 2024 These exciting players could deliver explosive growth over time. Via The Motley Fool 3 Revolutionary Biotech Stocks Poised for 10X Surge February 19, 2024 Discover three biotech stocks set to soar in a $3.08 trillion market, merging medical innovations with financial growth opportunities. Via InvestorPlace 3 Magnificent Growth Stocks to Buy Right Now February 19, 2024 These stocks share at least two common denominators: a biopharmaceutical focus and great long-term prospects. Via The Motley Fool Could This News Upset Vertex Pharmaceuticals' Prospects in the Billion-Dollar Pain Management Market? February 18, 2024 The pain market is in great need of new options. Via The Motley Fool 2 Top Growth Stocks to Buy With $1,000 Right Now February 18, 2024 Even a modest starting investment in the right stocks could pay off in the years ahead. Via The Motley Fool Vertex Pharmaceuticals Will Use $100 Million to Tank Its Own Market Share. Here's Why That's a Smart Move. February 17, 2024 Sometimes, the winning move doesn't look right at first. Via The Motley Fool 2 Healthcare Growth Stocks That Are No-Brainer Buys Right Now February 17, 2024 The healthcare industry often remains resilient amid macro headwinds, and these two stocks are prime examples. Via The Motley Fool Giving Uber Its Due February 15, 2024 We've also got a look at good news from Chipotle and Roblox, and we put some stocks on a dating show. Via The Motley Fool Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade. February 15, 2024 These stocks have what it takes to drive superior returns in the years to come. Via The Motley Fool Gene therapy: Why does it cost millions for a single treatment? February 15, 2024 Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology. Via MarketBeat Exposures Product Safety Is Vertex Pharmaceuticals Stock Too Expensive With a Price-to-Sales Ratio of 11x? February 15, 2024 There's more to consider with Vertex's valuation than one number. Via The Motley Fool If You Invested $10,000 in Vertex Pharmaceuticals in 2014, This Is How Much You Would Have Today February 13, 2024 You can't go back in the past, but it's not too late to invest in this top stock. Via The Motley Fool European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia February 13, 2024 From Vertex Pharmaceuticals Incorporated Via Business Wire 2 Healthcare Stocks That Could Help Set You Up for Life February 12, 2024 These rock-solid businesses can add meaningful returns to a long-term portfolio. Via The Motley Fool 3 Groundbreaking Healthcare Stocks to Buy for Robust Gains February 11, 2024 Get the latest investment advice for healthcare stocks in 2024. Discover top picks and growth opportunities for the healthcare sector. Via InvestorPlace Is Vertex Pharmaceuticals Stock a Buy Now? February 10, 2024 The company just released its latest earnings report, and growth investors may be a little disappointed. Via The Motley Fool 2 Healthcare Stocks You Can Buy and Hold for the Next Decade February 10, 2024 These businesses are built to last. Via The Motley Fool 2 No-Brainer Healthcare Stocks to Buy Right Now February 10, 2024 Companies in the healthcare industry tend to generate returns in a wide range of market environments. Via The Motley Fool 3 Stocks That Could Trounce the Market in 2024 February 10, 2024 These stocks appear to have what it takes to beat the market this year. Via The Motley Fool < Previous 1 2 3 4 5 6 7 8 9 ... 48 49 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.